These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 427755
21. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure. Cupid BC, Lightfoot TJ, Russell D, Gant SJ, Turner PC, Dingley KH, Curtis KD, Leveson SH, Turteltaub KW, Garner RC. Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179 [Abstract] [Full Text] [Related]
22. Activation of chemical carcinogens by cultured human fetal liver, esophagus and stomach. Autrup H, Harris CC, Wu SM, Bao LY, Pei XF, Lu S, Sun TT, Hsia CC. Chem Biol Interact; 1984 Jun; 50(1):15-25. PubMed ID: 6329529 [Abstract] [Full Text] [Related]
23. Microsome-dependent binding of benzo(alpha)pyrene and aflatoxin B1 to DNA, and benzo(alpha)pyrene binding to aflatoxin-conjugated DNA. Alexandrov K, Frayssinet C. Cancer Res; 1974 Dec; 34(12):3289-95. PubMed ID: 4154143 [No Abstract] [Full Text] [Related]
24. Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Haugen A, Groopman JD, Hsu IC, Goodrich GR, Wogan GN, Harris CC. Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4124-7. PubMed ID: 6794029 [Abstract] [Full Text] [Related]
28. In vitro metabolism of aflatoxin B2 by animal and human liver. Roebuck BD, Siegel WG, Wogan GN. Cancer Res; 1978 Apr; 38(4):999-1002. PubMed ID: 639051 [Abstract] [Full Text] [Related]
33. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin. Essigmann JM, Donahue PR, Story DL, Wogan GN, Brunengraber H. Cancer Res; 1980 Nov; 40(11):4085-91. PubMed ID: 6781740 [No Abstract] [Full Text] [Related]
35. Interspecies differences in the major DNA adducts formed from benzo(a)pyrene but not 7,12-dimethylbenz(a)anthracene in rat and human mammary cell cultures. Moore CJ, Pruess-Schwartz D, Mauthe RJ, Gould MN, Baird WM. Cancer Res; 1987 Aug 15; 47(16):4402-6. PubMed ID: 3111685 [Abstract] [Full Text] [Related]
36. Strain differences in the metabolic activation of aflatoxin B1 in the rat. Plummer S, Boobis AR, Davies DS. Xenobiotica; 1987 Feb 15; 17(2):199-208. PubMed ID: 3105188 [Abstract] [Full Text] [Related]
37. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis. Zhang YJ, Chen CJ, Haghighi B, Yang GY, Hsieh LL, Wang LW, Santella RM. Cancer Res; 1991 Mar 15; 51(6):1720-5. PubMed ID: 1900216 [Abstract] [Full Text] [Related]
38. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene. Lu LJ, Disher RM, Reddy MV, Randerath K. Cancer Res; 1986 Jun 15; 46(6):3046-54. PubMed ID: 3698023 [Abstract] [Full Text] [Related]
39. DNA binding and adduct formation of aflatoxin B1 in cultured human and animal tracheobronchial and bladder tissues. Stoner GD, Daniel FB, Schenck KM, Schut HA, Sandwisch DW, Gohara AF. Carcinogenesis; 1982 Jun 15; 3(11):1345-8. PubMed ID: 6817939 [No Abstract] [Full Text] [Related]
40. Does aflatoxin exposure in the United Kingdom constitute a cancer risk? Harrison JC, Carvajal M, Garner RC. Environ Health Perspect; 1993 Mar 15; 99():99-105. PubMed ID: 8319666 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]